Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 69 |
| List of Tables | 61 | 9 |
| List of Figures | 70 | 1 |
| Introduction | 71 | 1 |
| Global Markets Direct Report Coverage | 71 | 1 |
| Pancreatic Cancer Overview | 72 | 1 |
| Therapeutics Development | 73 | 2 |
| Pipeline Products for Pancreatic Cancer Overview | 73 | 1 |
| Pipeline Products for Pancreatic Cancer Comparative Analysis | 74 | 1 |
| Pancreatic Cancer Therapeutics under Development by Companies | 75 | 26 |
| Pancreatic Cancer Therapeutics under Investigation by Universities/Institutes | 101 | 3 |
| Pancreatic Cancer Pipeline Products Glance | 104 | 4 |
| Late Stage Products | 104 | 1 |
| Clinical Stage Products | 105 | 1 |
| Early Stage Products | 106 | 1 |
| Unknown Stage Products | 107 | 1 |
| Pancreatic Cancer Products under Development by Companies | 108 | 33 |
| Pancreatic Cancer Products under Investigation by Universities/Institutes | 141 | 4 |
| Pancreatic Cancer Companies Involved in Therapeutics Development | 145 | 282 |
| 3-V Biosciences, Inc. | 145 | 1 |
| 4SC AG | 146 | 1 |
| AB Science SA | 147 | 1 |
| AbbVie Inc. | 148 | 1 |
| AbGenomics International, Inc. | 149 | 1 |
| Ability Pharmaceuticals, S.L. | 150 | 1 |
| Acetylon Pharmaceuticals, Inc. | 151 | 1 |
| ACF Pharmaceuticals, LLC | 152 | 1 |
| Adamed Sp. z o.o. | 153 | 1 |
| Adamis Pharmaceuticals Corporation | 154 | 1 |
| Aduro BioTech, Inc. | 155 | 1 |
| Advantagene, Inc. | 156 | 1 |
| Advaxis, Inc. | 157 | 1 |
| Agenus, Inc. | 158 | 1 |
| AGV Discovery, SAS | 159 | 1 |
| AIMM Therapeutics B.V. | 160 | 1 |
| Alchemia Limited | 161 | 1 |
| Alethia Biotherapeutics Inc. | 162 | 1 |
| Allinky Biopharma | 163 | 1 |
| Almac Discovery Limited | 164 | 1 |
| Altor BioScience Corporation | 165 | 1 |
| Ambrx, Inc. | 166 | 1 |
| American Gene Technologies International Inc. | 167 | 1 |
| Amgen Inc. | 168 | 1 |
| Anavex Life Sciences Corp. | 169 | 1 |
| Andarix Pharmaceuticals, Inc. | 170 | 1 |
| ANP Technologies, Inc. | 171 | 1 |
| AntiCancer, Inc. | 172 | 1 |
| APEIRON Biologics AG | 173 | 1 |
| Aphios Corporation | 174 | 1 |
| APIM Therapeutics AS | 175 | 1 |
| Apogenix GmbH | 176 | 1 |
| Aposense Ltd. | 177 | 1 |
| ArQule, Inc. | 178 | 1 |
| Array BioPharma Inc. | 179 | 1 |
| Astellas Pharma Inc. | 180 | 1 |
| AstraZeneca Plc | 181 | 1 |
| ATLAB Pharma SAS | 182 | 1 |
| Aurigene Discovery Technologies Limited | 183 | 1 |
| AVEO Pharmaceuticals, Inc. | 184 | 1 |
| Axcentua Pharmaceuticals AB | 185 | 1 |
| Azaya Therapeutics, Inc. | 186 | 1 |
| Basilea Pharmaceutica AG | 187 | 1 |
| Bavarian Nordic A/S | 188 | 1 |
| Bayer AG | 189 | 1 |
| Bellicum Pharmaceuticals, Inc. | 190 | 1 |
| Berg LLC | 191 | 1 |
| BerGenBio AS | 192 | 1 |
| Betta Pharmaceuticals Co. Ltd. | 193 | 1 |
| Bexion Pharmaceuticals, LLC. | 194 | 1 |
| Biomar Microbial Technologies | 195 | 1 |
| Biomunex Pharmaceuticals | 196 | 1 |
| Bioncotech Therapeutics S.L. | 197 | 1 |
| Bionomics Limited | 198 | 1 |
| BioNTech AG | 199 | 1 |
| BiOrion Technologies B.V. | 200 | 1 |
| Biotest AG | 201 | 1 |
| Biouniversa s.r.l. | 202 | 1 |
| Boehringer Ingelheim GmbH | 203 | 1 |
| Boston Biomedical, Inc. | 204 | 1 |
| Bristol-Myers Squibb Company | 205 | 1 |
| Cadila Pharmaceuticals Limited | 206 | 1 |
| Calithera Biosciences, Inc. | 207 | 1 |
| Cantargia AB | 208 | 1 |
| Cascadian Therapeutics Inc | 209 | 1 |
| Cavion LLC | 210 | 1 |
| Celgene Corporation | 211 | 1 |
| Cellceutix Corporation | 212 | 1 |
| Cellectis S.A. | 213 | 1 |
| Cellular Biomedicine Group, Inc. | 214 | 1 |
| Celprogen, Inc. | 215 | 1 |
| Celsion Corporation | 216 | 1 |
| Centrose LLC | 217 | 1 |
| Ceronco Biosciences | 218 | 1 |
| ChemoCentryx, Inc. | 219 | 1 |
| Chiome Bioscience, Inc. | 220 | 1 |
| Clovis Oncology, Inc. | 221 | 1 |
| Coare Biotechnology, Inc. | 222 | 1 |
| Concordia Healthcare Corp. | 223 | 1 |
| Confluence Life Sciences, Inc. | 224 | 1 |
| Cornerstone Pharmaceuticals, Inc. | 225 | 1 |
| Critical Outcome Technologies Inc. | 226 | 1 |
| CritiTech, Inc. | 227 | 1 |
| CrystalGenomics, Inc. | 228 | 1 |
| CTI BioPharma Corp. | 229 | 1 |
| Cyclacel Pharmaceuticals, Inc. | 230 | 1 |
| CytomX Therapeutics, Inc. | 231 | 1 |
| CytRx Corporation | 232 | 1 |
| CyTuVax B.V. | 233 | 1 |
| Daewoong Pharmaceutical Co., Ltd. | 234 | 1 |
| DEKK-TEC, Inc. | 235 | 1 |
| Dicerna Pharmaceuticals, Inc. | 236 | 1 |
| Diffusion Pharmaceuticals Inc. | 237 | 1 |
| Eisai Co., Ltd. | 238 | 1 |
| Eleison Pharmaceuticals LLC | 239 | 1 |
| Eli Lilly and Company | 240 | 1 |
| Endor Nanotechnologies SL | 241 | 1 |
| Ensol Biosciences Inc. | 242 | 1 |
| Erytech Pharma SA | 243 | 1 |
| Esperance Pharmaceuticals, Inc. | 244 | 1 |
| Etubics Corporation | 245 | 1 |
| Exelixis, Inc. | 246 | 1 |
| F. Hoffmann-La Roche Ltd. | 247 | 1 |
| FibroGen, Inc. | 248 | 1 |
| Five Prime Therapeutics, Inc. | 249 | 1 |
| Forty Seven Inc. | 250 | 1 |
| Fountain Biopharma Inc. | 251 | 1 |
| Fujifilm Corporation | 252 | 1 |
| Fusion Antibodies Limited | 253 | 1 |
| GamaMabs Pharma S.A. | 254 | 1 |
| Ganymed Pharmaceuticals AG | 255 | 1 |
| Geistlich Pharma AG | 256 | 1 |
| Genelux Corporation | 257 | 1 |
| Genentech, Inc. | 258 | 1 |
| Genisphere Inc. | 259 | 1 |
| Genmab A/S | 260 | 1 |
| Gilead Sciences, Inc. | 261 | 1 |
| GlaxoSmithKline Plc | 262 | 1 |
| Globeimmune, Inc. | 263 | 1 |
| GlycoMimetics, Inc. | 264 | 1 |
| Golden Biotechnology Corp. | 265 | 1 |
| GW Pharmaceuticals Plc | 266 | 1 |
| Halozyme Therapeutics, Inc. | 267 | 1 |
| HEC Pharm Co., Ltd. | 268 | 1 |
| Helix BioPharma Corp. | 269 | 1 |
| iCeutica, Inc. | 270 | 1 |
| Ignyta, Inc. | 271 | 1 |
| Immodulon Therapeutics Ltd. | 272 | 1 |
| Immune Pharmaceuticals Inc. | 273 | 1 |
| Immune System Key Ltd. | 274 | 1 |
| Immunomedics, Inc. | 275 | 1 |
| Immunotope, Inc. | 276 | 1 |
| Immunovo BV | 277 | 1 |
| Immupharma Plc | 278 | 1 |
| Incuron, LLC | 279 | 1 |
| Incyte Corporation | 280 | 1 |
| Inflection Biosciences Limited | 281 | 1 |
| Innopharmax Inc. | 282 | 1 |
| Inovio Pharmaceuticals, Inc. | 283 | 1 |
| Intica Biomedical, Inc. | 284 | 1 |
| Inventiva | 285 | 1 |
| Io Therapeutics, Inc. | 286 | 1 |
| Ipsen S.A. | 287 | 1 |
| Jasco Pharmaceuticals, LLC. | 288 | 1 |
| Jiangsu Hengrui Medicine Co., Ltd. | 289 | 1 |
| Johnson &Johnson | 290 | 1 |
| Juno Therapeutics Inc. | 291 | 1 |
| Kadmon Corporation, LLC | 292 | 1 |
| Kancera AB | 293 | 1 |
| Karcinolys SAS | 294 | 1 |
| Karyopharm Therapeutics, Inc. | 295 | 1 |
| Keystone Nano, Inc. | 296 | 1 |
| Komipharm International Co., Ltd. | 297 | 1 |
| Kura Oncology, Inc. | 298 | 1 |
| Kyowa Hakko Kirin Co., Ltd. | 299 | 1 |
| Lymphocyte Activation Technologies, S.A. | 300 | 1 |
| MabVax Therapeutics Holdings, Inc. | 301 | 1 |
| MacroGenics, Inc. | 302 | 1 |
| Mateon Therapeutics Inc | 303 | 1 |
| MaxiVAX SA | 304 | 1 |
| Meabco A/S | 305 | 1 |
| Mebiopharm Co., Ltd. | 306 | 1 |
| MediaPharma s.r.l. | 307 | 1 |
| Medicenna Therapeutics, Inc. | 308 | 1 |
| MedImmune, LLC | 309 | 1 |
| Medisyn Technologies, Inc. | 310 | 1 |
| Medivation, Inc. | 311 | 1 |
| Merck &Co., Inc. | 312 | 1 |
| Merck KGaA | 313 | 1 |
| Merrimack Pharmaceuticals, Inc. | 314 | 1 |
| Merus B.V. | 315 | 1 |
| Midatech Pharma Plc | 316 | 1 |
| MolMed S.p.A. | 317 | 1 |
| Momenta Pharmaceuticals, Inc. | 318 | 1 |
| Monopar Therapeutics LLC | 319 | 1 |
| Morphotek, Inc. | 320 | 1 |
| Multimmune GmbH | 321 | 1 |
| Mundipharma International Ltd | 322 | 1 |
| NanoCarrier Co., Ltd. | 323 | 1 |
| NantKwest, Inc. | 324 | 1 |
| Nascent Biotech, Inc. | 325 | 1 |
| Natco Pharma Limited | 326 | 1 |
| NatureWise Biotech &Medicals Corporation | 327 | 1 |
| Nerviano Medical Sciences S.r.l. | 328 | 1 |
| NewLink Genetics Corporation | 329 | 1 |
| NormOxys, Inc. | 330 | 1 |
| Northwest Biotherapeutics, Inc. | 331 | 1 |
| Novartis AG | 332 | 1 |
| NuCana BioMed Limited | 333 | 1 |
| Omeros Corporation | 334 | 1 |
| Omnitura Therapeutics Inc. | 335 | 1 |
| Oncodesign SA | 336 | 1 |
| Oncodrone BV | 337 | 1 |
| Oncology Research International Limited | 338 | 1 |
| Oncolytics Biotech Inc. | 339 | 1 |
| Oncomatryx Biopharma, S.L. | 340 | 1 |
| OncoMed Pharmaceuticals, Inc. | 341 | 1 |
| Oncovir, Inc. | 342 | 1 |
| Ono Pharmaceutical Co., Ltd. | 343 | 1 |
| Opsona Therapeutics Limited | 344 | 1 |
| Optimum Therapeutics, LLC | 345 | 1 |
| Oribase Pharma | 346 | 1 |
| Oryx GmbH &Co. KG | 347 | 1 |
| Oscotec Inc. | 348 | 1 |
| Pfizer Inc. | 349 | 1 |
| Pharma Mar, S.A. | 350 | 1 |
| Pharma Two B Ltd | 351 | 1 |
| PharmAbcine, Inc. | 352 | 1 |
| Pharmacyclics, Inc. | 353 | 1 |
| PharmaCyte Biotech, Inc. | 354 | 1 |
| Pharmedartis GmbH | 355 | 1 |
| Phoenix Biotechnology, Inc. | 356 | 1 |
| Pique Therapeutics | 357 | 1 |
| Plexxikon Inc. | 358 | 1 |
| Polaris Pharmaceuticals, Inc. | 359 | 1 |
| Precision Biologics, Inc. | 360 | 1 |
| Prima BioMed Ltd. | 361 | 1 |
| Provectus Biopharmaceuticals, Inc. | 362 | 1 |
| Quest PharmaTech Inc. | 363 | 1 |
| Quimatryx, S.L. | 364 | 1 |
| Raptor Pharmaceutical Corp. | 365 | 1 |
| RedHill Biopharma Ltd. | 366 | 1 |
| Redx Pharma Plc | 367 | 1 |
| RESprotect GmbH | 368 | 1 |
| Rexahn Pharmaceuticals, Inc. | 369 | 1 |
| Rigontec GmbH | 370 | 1 |
| Sanofi | 371 | 1 |
| Sareum Holdings Plc | 372 | 1 |
| Satt Nord SAS | 373 | 1 |
| Savoy Pharmaceuticals, Inc. | 374 | 1 |
| SignPath Pharma Inc | 375 | 1 |